Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5200804
Max Phase: Preclinical
Molecular Formula: C29H36N2O12
Molecular Weight: 604.61
Associated Items:
ID: ALA5200804
Max Phase: Preclinical
Molecular Formula: C29H36N2O12
Molecular Weight: 604.61
Associated Items:
Canonical SMILES: C=C[C@H]1[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)OC=C(C(=O)OC)[C@H]1CC(=O)c1[nH]c2ccccc2c1[C@H](OC)C(=O)NC
Standard InChI: InChI=1S/C29H36N2O12/c1-5-13-15(10-18(33)21-20(25(39-3)26(37)30-2)14-8-6-7-9-17(14)31-21)16(27(38)40-4)12-41-28(13)43-29-24(36)23(35)22(34)19(11-32)42-29/h5-9,12-13,15,19,22-25,28-29,31-32,34-36H,1,10-11H2,2-4H3,(H,30,37)/t13-,15+,19-,22-,23+,24-,25+,28+,29+/m1/s1
Standard InChI Key: WJGZLZMGWNYJFB-LTVUNUHGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 604.61 | Molecular Weight (Monoisotopic): 604.2268 | AlogP: -0.18 | #Rotatable Bonds: 11 |
Polar Surface Area: 206.10 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.72 | CX Basic pKa: | CX LogP: -0.78 | CX LogD: -0.78 |
Aromatic Rings: 2 | Heavy Atoms: 43 | QED Weighted: 0.11 | Np Likeness Score: 1.46 |
1. Shi BB, Ai HL, Duan KT, Feng T, Liu JK.. (2022) Ophiorrhines F and G, Key Biogenetic Intermediates of Ophiorrhine Alkaloids from Ophiorrhiza japonica and Their Immunosuppressant Activities., 85 (2.0): [PMID:35104138] [10.1021/acs.jnatprod.1c01085] |
Source(1):